Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential Hypertension

Clinical trial NCT07064525 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07064525
Sponsor: Shin Poong Pharmaceutical Co. Ltd.
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertension (HTN)NYHA Class III Heart Failure NYHA Class IV Heart Failure Diabete Mellitus

Start date: 2024-12-05
Primary completion: 2025-12-15
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.